Technology Opportunity, Ref. No. UZNovel nanomolar inhibitor of Eph tyrosine kinases New small molecule inhibitors of Eph kinases have been developed which have potential therapeutic application in angiogenesis

First Page		Document Content
Date: 2014-02-01 16:41:28 Tyrosine kinase receptors Tyrosine kinase Protein kinase Ephrin Proto-oncogene tyrosine-protein kinase Src Imatinib Kinase C-Met Non-receptor tyrosine kinase Receptor tyrosine kinase		Technology Opportunity, Ref. No. UZNovel nanomolar inhibitor of Eph tyrosine kinases New small molecule inhibitors of Eph kinases have been developed which have potential therapeutic application in angiogenesis Add to Reading List Source URL: www.switt.ch Download Document from Source Website File Size: 208,45 KB Share Document on Facebook

	Microsoft Word - abstracts_compiled.doc DocID: 1rn3E - View Document
	Abstract ErbB2 overexpression gives rise to a highly invasive, aggressive phenotype associated with an enlarged lysosomal compartment and increased activity of the lysosomal proteases, cysteine cathepsins. We have recent DocID: 1rdcC - View Document
	CME A Look at the Near Future of Lung Cancer Treatment Dates of certification: May 31, 2016, to May 31, 2017 Medium: Print with online posttest, evaluation, and request for credit DocID: 1qVsW - View Document
	2014 Annual Report Centre for Cancer Biology DocID: 1qRyU - View Document
	Wrangling Phosphoproteomic Data to Elucidate Cancer Signaling Pathways Mark L. Grimes1*, Wan-Jui Lee2, Laurens van der Maaten2, Paul Shannon3 1 Division of Biological Sciences, University of Montana, Missoula, Montana, U DocID: 1qMPs - View Document